A common mechanism for high affinity carbohydrate uptake in microbial species is the phosphoenolpyruvate-dependent phosphotransferase system (PTS). This system consists of a shared component, EI, which is required for all PTS transport, and numerous carbohydrate uptake transporters. In Vibrio cholerae, there are 13 distinct PTS transporters. Due to genetic redundancy within this system, the carbohydrate specificity of each of these transporters is not currently defined. Here, using multiplex genome editing by natural transformation (MuGENT), we systematically dissect PTS transport in V. cholerae. Specifically, we generated a mutant strain that lacks all 13 PTS transporters, and from this strain, we created a panel of mutants where each expresses a single transporter. Using this panel, we have largely defined the carbohydrate specificities of each PTS transporter. In addition, this analysis uncovered a novel glucose transporter. We have further defined the mechanism of this transporter and characterized its regulation. Using our 13 PTS transporter mutant, we also provide the first clear evidence that carbohydrate transport by the PTS is not essential during infection in an infant mouse model of cholera. In summary, this study shows how multiplex genome editing can be used to rapidly dissect complex biological systems and genetic redundancy in microbial systems.
Introduction
Microbial species have the capacity to utilize diverse carbohydrates. One mechanism for high affinity uptake of carbohydrates is the highly conserved PTS. This system is comprised of a phosphotransfer cascade that catalyzes the transfer of phosphate from phosphoenolpyruvate (PEP) to a carbohydrate substrate concomitant with its entry into the cytoplasm (Deutscher et al., 2006; McCoy et al., 2016) . This phosphorylation serves to retain this carbohydrate in the cytoplasm and to prime it for downstream metabolism (Roseman, 1969; Deutscher et al., 2006) . The first step of this phosphotransfer cascade is carried out by Enzyme I (EI), which is highly conserved and shared by all PTS transporters. EI autophosphorylates in the presence of PEP and then subsequently transfers this phosphate to HPr (or the HPr homolog FPr) (Fig. 1A) . The phosphate from HPr is then passed to Enzyme II (EII) complexes, which make up the PTS transporters. The EII complexes consist of three domains known as EIIA, EIIB, and EIIC. These complexes can either have all three domains in the same protein (i.e., an EIIABC protein), or can be encoded by distinct proteins. The EIIA domain receives the phosphate from HPr and passes this phosphate to the EIIB domain (Fig. 1A) . The phosphate from EIIB is then passed to the incoming carbohydrate as it is transported across the inner membrane by the integral membrane EIIC domain (Fig. 1A) . The EIIC domain defines the carbohydrate specificity within these transport systems. There are 13 distinct EIIC-domain containing genes in Vibrio cholerae (Supporting Information Table  S1 ) (Houot et al., 2010b) . Translocation of a carbohydrate across the membrane is concerted with and requires this phosphoryl transfer. Indeed, in the absence of shared components of the PTS (EI and HPr), translocation of carbohydrates is largely inhibited (Postma and Stock, 1980) . While the dominant substrates for these transporters are largely predicted through homology, empirical evidence demonstrating the substrate specificities of each system is currently lacking. Also, some PTS EIIC transporters can translocate more than one substrate, which can result in overlapping substrate specificity amongst gene members within this class (Jones-Mortimer and Kornberg, 1976; Liberman and Bleiweis, 1984; Decker et al., 1999; Abranches et al., 2003) . As a result, analysis of PTS transport via the use of single transporter mutant strains cannot fully define the range of substrates translocated by each PTS transporter.
Characterizing phenotypes associated with PTS transport is classically accomplished using mutants lacking early components of the PTS (i.e., mutation of EI or HPr). This, however, can have pleiotropic effects in the cell due to a regulatory role for the PTS in controlling adenylate cyclase activity via the phosphorylation state of EIIA Glc (Deutscher et al., 2006) . Adenylate cyclase produces cyclic AMP (cAMP), which globally affects regulation through the cAMP receptor protein (CRP), which is also known as the catabolite activator protein (CAP). In addition to its role in indirectly regulating CRP, EIIA Glc can also directly modulate the activity of a number of proteins in a phosphorylation-dependent manner (Deutscher et al., 2006) . Thus, in EI and HPr mutants, in addition to eliminating PTS-dependent carbohydrate transport, CRP and EIIA Glc activity is altered, which results in global regulatory changes in the cell. Due to the large number of transporters in this system, it has been difficult to uncouple PTS transport from these regulatory effects. Here, we have overcome these limitations in the cholera pathogen, V. cholerae, by exploiting multiplex genome editing by natural transformation (MuGENT) (Dalia et al., 2014b) . Using this method, we rapidly generated a mutant strain that lacks all 13 EIIC domaincontaining genes as well as a panel of strains where each expresses a single PTS transporter. In addition to defining the carbohydrate specificity of these transporters, this analysis has also uncovered a novel glucose transporter in this important human pathogen. Furthermore, we use these mutants to clearly define the role of PTS transport during infection of a mammalian host.
Results

Genetic dissection of PTS transport via MuGENT
To define the major carbohydrate specificity of each PTS transporter in V. cholerae, we first generated a strain where all 13 EIIC-domain containing genes were mutated. These 13 loci were located throughout both chromosomes of V. cholerae and it took 5 cycles of MuGENT to generate a tredecuple mutant where all of these genes were mutated in a single strain (Fig. 1B) . To screen for mutations during MuGENT and to confirm that all 13 genes were mutated in our D13IIC strain, we performed 2 separate multiplex allele-specific colony PCRs (MASC-PCRs) (Wang et al., 2009) (Fig. 1C) . A common concern with multiplex genome editing is the generation of off-target mutations (Isaacs et al., 2011; Nyerges et al., 2014; Kim et al., 2015; Kleinstiver et al., 2016). To determine if MuGENT introduced off-target mutations after editing 13 genetic loci, we whole genome sequenced the D13IIC strain via short reads (50 bp) on the Illumina platform and obtained an average mapped coverage depth of $503. We then analyzed these data for the presence of single nucleotide variants and short insertions/deletions ( 5 bp); however, we found no evidence for any off-target mutations in this strain. Next, we generated a panel of strains where each contains only a single PTS transporter by independently reverting the mutation of each PTS transporter in the D13IIC strain (Fig. 1C) . Reversion to the wildtype sequence was confirmed in each strain by conventional Sanger sequencing. Strains that express only a single PTS transporter are referred to as "pts####" where the number indicates the genetic locus of the transporter. So, pts2013 indicates that this strain is wildtype for VC2013, while the genes for the other 12 IICdomain containing proteins are mutated. To define the carbohydrate specificity of each transporter, we then grew this panel of strains on M9 minimal medium containing defined carbon sources (Table 1) . This analysis uncovered transporters that have the ability to translocate multiple carbon sources as well as redundancy amongst PTS transporters. For example, we find that VC2013 and VC1826 are independently capable of supporting growth in minimal medium supplemented with mannose as the sole carbon source ( Fig. 1D and Table  1 ) (Houot et al., 2010a) . VC2013 is a homolog of PtsG, the canonical glucose PTS transporter and, as such, also supports growth on glucose as the sole carbon source (Table 1) . VC1826 on the other hand is also capable of supporting growth when fructose is supplied as the sole carbon source ( Fig. 1E and Table 1 ). Thus, this analysis has uncovered relationships between these transporters that would not have been possible via a single-gene knockout approach.
Identification of an EI-independent glucose PTS transporter
EI initiates the phosphotransfer cascade of the PTS and is, therefore, critical for translocation of carbohydrates by this system. As expected, utilization of most PTS transported carbohydrates in V. cholerae requires EI, with the exception of glucose (Table 1) . Paradoxically, while an EI mutant was still capable of growth on glucose, the D13IIC strain was not ( Fig. 2A and Table 1 ). This suggests that while PTS transporters are critical for uptake of glucose that at least one of these transporters (Zhang et al., 2003) and scored for growth (1) or no growth (2).
may function independently of EI. We found that there were three PTS transporters that were individually sufficient for growth on glucose: VC2013, VC0995, and VC1821. VC2013 is the V. cholerae PtsG homolog and is a predicted high-affinity glucose transporter, VC0995 is the sole GlcNAc PTS transporter (Table 1) , while VC1821 is a predicted fructose subclass PTS transporter (Supporting Information Table S1 ). While pts1821 and pts2013 both supported robust growth on glucose, they displayed slightly reduced growth compared with the wildtype ( Fig. 2A ). To test if maximal growth on glucose requires the additive function of both of these transporters, we compared growth of the VC1821 single mutant to the wildtype. These strains grew similarly (Supporting Information Fig. S1 ), thus, these transporters do not function additively. Reduced growth of the pts2013 strain compared with wildtype may suggest that activity/regulation of VC2013 is slightly reduced in the pts2013 strain background.
As an independent way of testing glucose utilization in these strains, we used MacConkey glucose plates. In this media, strains that can ferment glucose appear purple, while strains that cannot appear yellow/colorless. As expected, the wildtype strain is purple on this media, while the D13IIC strain is yellow. To test if one of the three PTS transporters sufficient for growth on glucose functions independently of EI, we mutated EI in strains expressing these transporters in isolation (i.e., in the pts2013, pts0995, and pts1821 strain backgrounds). We found that one, VC1821, allows for metabolism of glucose even in the absence of EI ( Fig. 2B and C) . Furthermore, we show that VC1821 is the major transporter capable of supporting EI-independent growth on glucose by generating a DEI DVC1821 mutant strain and showing that, compared with a DEI mutant, this strain loses the ability to grow on glucose (Fig. 2D) . Importantly, the ability of VC1821 to support EI-independent growth on glucose is not only seen in E7946, the strain used throughout this study, but was also observed in C6706 and A1552, two other commonly studied El Tor O1 isolates of V. cholerae (Fig. 2D ). EI-independent growth on glucose has also previously been observed in O139 isolates of V. cholerae (Houot and Watnick, 2008) .
EI-independent growth on glucose requires a ROK family glucokinase
Vibrio cholerae expresses an EI homolog, EI Ntr , which generally functions in a distinct system, PTS Ntr , to regulate genes involved in nitrogen assimilation (Pfl€ ugerGrau and G€ orke, 2010). To determine if EI Ntr was genetically redundant with EI and allowed for growth of V. cholerae on glucose, we generated a DEI DEI Ntr double mutant. This strain, however, was still capable of growth on glucose, suggesting that EI Ntr is not involved in EI-independent glucose transport through VC1821 (Supporting Information Fig. S2 ). VC1821 is a predicted EIIBC enzyme and contains the conserved phosphorylation site, cysteine 380, in its EIIB domain. To determine if this site is required for EI-independent growth on Systematic genetic dissection of PTS in Vibrio cholerae 571 glucose, we mutated this cysteine to alanine in strain pts1821. We found that this mutant was still capable of growth on glucose (Fig. 3A) . Conversely, mutating the conserved phosphorylation site in the EIIB domain of VC0995, the sole GlcNAc transporter, completely abrogates the ability of this strain to grow on GlcNAc (Fig. 3B) . We further tested the role of the EIIB domain in VC1821-dependent glucose transport by generating a strain lacking this domain in the pts1821 strain background. We found that the EIIB domain of VC1821 was dispensable for growth on glucose (Fig. 3C ). These results suggest that phosphorylation of glucose may be uncoupled from transport through VC1821, which is contrary to the paradigm of PTS-dependent transport (Postma and Stock, 1980) . Phosphorylation of glucose, however, would still be required to prime this carbohydrate for catabolism in the cell. In other organisms like Escherichia coli, when glucose is transported into the cell by ABC transporters or symporters, it is phosphorylated in the cytoplasm by glucokinases (Curtis and Epstein, 1975) . However, there is no apparent glucokinase homolog in V. cholerae. Carbohydrate kinases can be members of the "repressor open reading frame kinase" (ROK) family of proteins, and by homology we identified 3 putative ROK family members in V. cholerae. Deletion of each predicted ROK family member in the pts1821 background revealed that VC1532 was required for utilization of glucose via VC1821 (Fig. 3D) . These results suggest that VC1532 is a glucokinase in V. cholerae. To test this further, we replaced VC1532 with glk, the well-defined glucokinase from E. coli (Meyer et al., 1997) , in the pts1821 strain background. We found that Glk was able to support growth of V. cholerae on glucose in the pts1821 background, providing genetic evidence that VC1532 is, indeed, a glucokinase in V. cholerae (Fig. 3E) . We also replaced VC1532 with mak, the manno(fructo)kinase from E. coli (Sebastian and Asensio, 1972) , in the pts1821 strain. This allowed us to test the promiscuity of VC1821 transport by testing whether the DVC1532::mak strain could now grow on fructose or mannose. This strain, however, did not support growth on these carbon sources (Supporting Information Fig. S3 ). Thus, despite falling within the fructose subclass of PTS transporters, VC1821 appears to be a relatively specific glucose transporter.
Next, we used an established coupled enzyme biochemical assay to determine if VC1532 possessed glucokinase activity (Skarlatos and Dahl, 1998) . In this assay, glucose is provided as a substrate and if glucokinase activity is present, glucose is converted to glucose-6-P (G6P). Then, Glucose-6-phosphate dehydrogenase (G6PDH) is provided in excess, which converts G6P to 6-phospho-D-glucono-1,5-lactone using A-C and E. Growth curves of the indicated strains in M9 minimal medium supplemented with (A, C, and E) glucose or (B) GlcNAc. In A and B, the mutated cysteine is the conserved phosphorylation site in the EIIB domains of the indicated genes. In E, glk is the glucokinase gene, while mak is the manno(fructo)kinase gene from E. coli. D. Strains with the indicated mutations in the pts1821 parent strain were spotted onto a MacConkey glucose agar plate. F. Glucokinase activity in the indicated cell lysate. Glucokinase activity was specifically detected by comparing reactions where glucose was added (1Glu) to those where no glucose was added (2Glu). All data in A-F are representative of at least two independent experiments. Intracellular levels of glucose (G) and glucose-6-P (H) were measured in the indicated cell extracts. Data in G and H are from three independent biological replicates. *** 5 p < 0.001.
NADP as a cofactor. Reduction of NADP to NADPH is monitored kinetically by measuring the absorbance at 340 nm (A 340 ). The rate-limiting step in this reaction is conversion of glucose to G6P; thus, this is an indirect but specific readout for glucokinase activity. Using this assay, we tested glucokinase activity in cell lysates of pts1821 and pts1821 DVC1532 strains and found robust activity only in the pts1821 strain (Fig. 3F) . In addition, no activity was observed when glucose was omitted; further supporting that the activity observed was due to a glucokinase (Fig. 3F) .
Based on our data indicating that phosphorylation is uncoupled from transport through VC1821, we would predict that glucose enters cells through this transporter in an unphosphorylated form and is subsequently phosphorylated in the cytoplasm through the action of VC1532. To more formally test this hypothesis, we assessed intracellular levels of glucose and G6P in cells after incubation in M9 1 Glucose. We found that intracellular unphosphorylated glucose was present in the pts1821 DVC1532 strain while it was not detectable in the pts1821 strain background (Fig. 3G) . Furthermore, glucose was not detected in the D13IIC DVC1532 strain, which indicates that the glucose detected in the pts1821 DVC1532 strain is, indeed, intracellular (Fig. 3G) . We also assessed intracellular G6P. In cells capable of metabolizing G6P, this molecule is rapidly catabolized. Mutants that lack phosphoglucose isomerase (PGI) and G6PDH, however, accumulate intracellular G6P (Fraenkel, 1968) . Consistent with this, G6P levels increase in the pts1821 DPGI DG6PDH (Fig. 3H) . Thus, to further test whether G6P forms in pts1821 in the absence of VC1532, we assessed intracellular G6P levels in a pts1821 DVC1532 DPGI DG6PDH mutant. The levels observed in this mutant were near the limit of detection in this assay and similar to a D13IIC DVC1532 DPGI DG6PDH mutant. In addition, we still observe accumulation of intracellular unphosphorylated glucose in the pts1821 DVC1532 DPGI DG6PDH mutant.
Cumulatively, these results are consistent with glucose being transported into the cytoplasm via VC1821 in an unphosphorylated form. This glucose is then phosphorylated to G6P via the action of the glucokinase encoded by VC1532.
VC1821 is a low affinity transporter that promotes glucose uptake via facilitated diffusion PTS transporters generally have a high affinity for their substrates. One way to differentiate between highaffinity and low-affinity transporters is to grow strains with decreasing concentrations of substrate. For highaffinity transporters, the maximal growth rate, indicated by the slope in a growth curve, is expected to remain stable while the maximal growth yield is expected to decrease with decreasing concentrations of substrate. For a low-affinity transporter, both the maximal growth rate and the maximum growth yield should reduce as the concentration of substrate is lowered. When wildtype V. cholerae is grown on decreasing concentrations of glucose, we found that the maximum growth rate remains stable, while the maximum growth yield decreases, which is consistent with high-affinity transport (Fig. 4) . A strain expressing only the PtsG homolog VC2013 also displays the characteristics of high-affinity glucose transport (Fig. 4) . In contrast, the strain that only expresses VC1821 displays reduced maximal growth rates at decreasing concentrations of glucose, which is consistent with low-affinity transport (Fig. 4) . Coupled with our data demonstrating that VC1821 functions in conjunction with a glucokinase (Fig. 3D) , these results suggest that VC1821 is a novel glucose transporter that promotes uptake of this carbohydrate by facilitated diffusion in V. cholerae. 
Regulation of VC1821 uncovered by transposon mutagenesis and epistasis analysis
To determine other genetic requirements for utilization of glucose via VC1821, we performed a transposon screen in the pts1821 strain background on MacConkey glucose plates screening for loss of the ability to ferment glucose. Three genes identified by this approach were cyaA, VCA0519, and VC1825 (Fig. 5A ). VCA0519 (a homolog of E. coli FruR) and VC1825 (AraC family protein) are predicted DNA-binding transcriptional regulators, while CyaA encodes adenylate cyclase and modulates the activity of the global regulator CRP. We first assessed whether these regulators controlled expression of VC1821 by qRT-PCR. Indeed, we found that loss of any one of these three genes resulted in loss of VC1821 expression (Fig. 5B) . To determine whether these regulators act in the same genetic pathway, we assessed the expression of all three regulators in mutant strains lacking any one regulator by qRT-PCR (Supporting Information Fig. S4 ). From this analysis, we hypothesized a hierarchy of regulation, where CyaA (in conjunction with CRP) regulates the expression of VCA0519, VCA0519 in turn regulates VC1825 expression, and VC1825 regulates expression of VC1821 (Fig.  5C ). To test this model, we performed epistasis experiments by ectopically expressing cyaA, VC1825, and VCA0519 in mutant strains lacking each of these genes in the pts1821 strain background. When we performed this analysis, we found that ectopic expression of VC1825 or VCA0519 recovered growth of the VCA0519 mutant, while only ectopic expression of VC1825 recovered growth of the VC1825 mutant (Fig. 5D ). This result suggests that VC1825 acts downstream of VCA0519 as predicted by our qRT-PCR analysis (Fig. 5D and Supporting Information Fig. S4) . Surprisingly, only ectopic expression of CyaA recovered growth of the cyaA mutant (Fig. 5D ). Since a cyaA mutant had reduced levels of VCA0519 and VC1825 expression (Supporting Information Fig. S4 ), we predict that it acts upstream of these regulators, but hypothesize that it may have an additional role in regulating glucose utilization via VC1821 (i.e., via additional regulation of VC1821 and/or regulation of the putative glucokinase encoded by VC1532) (Fig. 5C and D) . VC1821 is also expressed in the WT strain when grown in rich medium. Importantly, cyaA, VC1825, and VCA0519 are also required for VC1821 expression in the wildtype background (Supporting Information Fig. S5 ).
PTS transport plays a limited role during infection of a mammalian host
Next, we tested the role of PTS-dependent carbohydrate transport during infection of a mammalian host using an infant mouse model of cholera. It was previously shown that an EI mutant is attenuated in this animal model (Merrell et al., 2002; Wang et al., 2015) . Indeed, we find this to be the case in our hands as well (median CI 5 0.065, p 5 0.014) (Fig. 6) . Mutation of early components of the PTS (like EI), however, can have pleiotropic effects in the cell by altering EIIA Glc dependent control of adenylate cyclase activity and, therefore, the activity of the global regulator CRP (Deutscher et al., 2006) . EIIA Glc can also exert regulatory affects independent of CRP (Maz e et al., 2014). Thus, it is difficult to uncouple the effect of an EI mutation on PTS-dependent transport from its regulatory effect in the cell. To overcome this, we employed our D13IIC mutant, which is incapable of transporting PTS-dependent carbohydrates, but still has an intact PTS, and therefore, maintains proper regulatory control of CRP activity. Surprisingly, this mutant is only modestly attenuated in vivo (median CI 5 0.623, p 5 0.0021) and is significantly less attenuated than the EI mutant, indicating that PTS dependent uptake of carbohydrates is not critical during infection (Fig. 6 ).
Discussion
Here, we have genetically dissected the PTS system in V. cholerae. This analysis has largely uncovered the substrate specificity of the transporters within this system and builds on previous studies that have characterized the PTS in this important human pathogen (Berg et al., 2007; Houot et al., 2010a,b; Kumar et al., 2011; Wang et al., 2015) . Many of these carbohydrate specificities are also supported by the proximity of genes putatively required for catabolism of the transported carbohydrate. The only gene we could not identify a substrate for was VC1211, which has a putative EIIC domain and EAL domain, the latter of which may facilitate cleavage of the second messenger cyclic-di-GMP. Also, there are no genes encoding other components of an enzyme II complex (i.e., EIIA or EIIB) in close proximity to this gene. Thus, VC1211 may not function as a bona fide PTS transporter, but may link EIIC function with regulation of c-di-GMP levels. Our genetic dissection of the PTS in V. cholerae also uncovered a glucose transporter that operates via an unexpected mechanism. It was previously reported that V. cholerae is capable of EI-independent growth on glucose (Houot and Watnick, 2008; Houot et al., 2010b) . Here we find that this growth requires a non-canonical PTS transporter encoded by VC1821. We further demonstrate that this transporter requires a glucokinase, VC1532, to promote uptake of glucose via facilitated diffusion. Therefore, we have named this transporter (VC1821) FdgA for facilitated diffusion of glucose and the glucokinase (VC1532) GlkA.
For most PTS transporters, translocation of the substrate across the membrane is tightly coupled to its phosphorylation (Postma and Stock, 1980) . Thus, in the absence of EI and other early components of the PTS, substrates cannot be transported through EII complexes. Mutant EII complexes, however, have been isolated where transport and phosphorylation are uncoupled (Ruijter et al., 1990; 1992; Kornberg et al., 2000; Plumbridge, 2000) . In these mutant EIIs, the substrate is transported via facilitated diffusion in the absence of EI. In addition, in many of these mutated EIIs, the substrate specificity of the transporter is relaxed (Ruijter et al., 1992; Plumbridge, 2000) . There are 2 examples of natural PTS transporters that have uncoupled transport from phosphorylation and both are from Lactobacillus species. One transports fucosyl-a-1,3-N-acetylglucosamine, while the other transports D-xylose via facilitated diffusion (Chaillou et al., 1999; Rodriguez-Diaz et al., 2012) . To our knowledge, FdgA, is the first natural PTS transporter described that promotes facilitated diffusion of glucose. Interestingly, the phosphorylation site of the EIIB domain of FdgA is conserved despite not being required for glucose transport. Therefore, in addition to allowing for facilitated diffusion of glucose, it is possible that FdgA may translocate another as yet unidentified carbohydrate using the canonical PTS, which requires this phosphorylation site. Indeed, the gene upstream of VC1821 encodes an EIIA component, which may complete this enzyme II complex.
According to our systematic analysis of PTS transport, FdgA is redundant with PtsG (encoded by VC2013) for glucose utilization in V. cholerae. Accordingly, we have not uncovered a phenotype for an FdgA mutant strain during growth on glucose in minimal medium (data not shown) and the physiological role for FdgA is currently unclear. FdgA, however, does provide V. cholerae with a mechanism for EI-independent glucose transport, which may be important under certain physiological conditions. For example, PTS transport is highly dependent on the PEP/pyruvate ratio of the cell (Hogema et al., 1998) . Since transport of glucose through FdgA is independent of the canonical PTS, it provides V. cholerae with a mechanism for uptake of glucose that is independent of the PEP/pyruvate ratio. EI-independent transport may also provide a route for glucose uptake in the presence of inhibitors of the PTS. The PTS is well conserved among microbial species and could be a target of natural antimicrobials. Indeed, the membrane components of the PTS have been identified as the targets for certain bacteriocins (Diep et al., 2007) . Natural inhibitors of the upstream steps in the PTS (e.g., EI) have not yet been identified, however, synthetic PTS inhibitors have recently been discovered (Ymele-Leki et al., 2012) . Houot et al. previously reported that glucose could enhance growth and biofilm formation in V. cholerae when the PTS was inactivated (Houot and Watnick, 2008) . This phenotype required growth on glucose in the absence of EI and other early components of the PTS. Here, we show that this growth requires the noncanonical PTS transporter FdgA. Thus, one role for FdgA may be to promote biofilm formation in V. cholerae in the absence of the PTS or when the PTS is suppressed, however, it is currently unclear what physiological conditions would require this activity. We also showed that EI-independent growth of multiple V. cholerae isolates is dependent on FdgA, and through bioinformatics analysis have found that this gene is well conserved among the Vibrionaceae. Thus, FdgA may promote EI-independent growth on glucose among diverse members of this genus.
It was previously shown that an EI mutant is attenuated in an adult germ free animal model of cholera (Houot et al., 2010a) . Also, V. cholerae mutants in the shared components of the PTS are attenuated in an infant mouse model of cholera (Wang et al., 2015) . The latter study suggests that this may be, in part, due to a role of PTS in regulating virulence gene expression (Wang et al., 2015) . They had not, however, excluded the possibility that V. cholerae requires PTS-transported carbohydrate(s) to effectively colonize the mammalian host. Here, we used our PTS transporter mutant (D13 EIIC) to specifically address the role of carbohydrate transport during infection. We found that this strain was surprisingly only modestly attenuated, suggesting that the major role for PTS in the animal host is for virulence gene expression. This result also suggests that utilization of PTS-dependent carbohydrates is not critical for infection. This could be for a number of reasons. One is that these carbohydrates are not available and/or not utilized in the host. Alternatively, loss of the ability to utilize PTS-dependent carbohydrates may not attenuate V. cholerae due to a redundancy in the carbon sources available during infection. Testing this latter hypothesis will be the focus of future work.
This study offers a paradigm for genetically dissecting a complex biological system in any organism where tools for multiplex genome editing have been developed. These include naturally competent microbes through the use of MuGENT (Dalia et al., 2014b) , those in which multiplex automated genome engineering (MAGE) operates (Wang et al., 2009) , and most recently in species where CRISPR/Cas9 is a functional means of editing/ selection (Jiang et al., 2013) . Thus, the approach outlined in this study can be applied to define genetic redundancy and complex genetic relationships in diverse pathogens and model systems.
Experimental procedures
Bacterial strains and culture conditions
Unless otherwise indicated, all V. cholerae strains used in this study are derived from E7946, a clinical isolate of V. cholerae collected in 1978 in Bahrain (Miller et al., 1989) . For a complete list of strains used in this study, see Supporting Information Table S2 . Strains were routinely grown in LB broth and on LB agar supplemented with Streptomycin (100 lg/ml), Kanamycin (50 lg/ml), Spectinomycin (200 lg/ml), Carbenicillin (20 lg/ml), and/or Trimethoprim (10 lg/ ml) when appropriate. Growth curves were performed in 13 M9 minimal medium (Difco) supplemented with the indicated carbon source to 1% unless otherwise indicated. No amino acids and/or vitamins were used to supplement this minimal medium. Strains were also spotted onto MacConkey Agar base medium (Difco) supplemented with glucose to 1% where indicated. Anaerobic growth was performed in a GasPak EZ system (BD) according to manufacturer's instructions.
Generation of mutant strains and constructs
All strains were generated by splicing-by-overlap extension (SOE) PCR and chitin-induced natural cotransformation/ MuGENT exactly as previously described (Dalia et al., 2014b) .
Briefly, MuGENT operates on the premise that a subpopulation of cells that are induced for natural competence are highly recombinogenic. Thus, this method involves cotransformation of two types of products -one that contains an antibiotic cassette for selection (referred to as the "selected product") and one or more products that generate a mutation of interest that does not contain any selectable marker (referred to as "unselected products"). Transformations are plated on media to select for integration of the selected product (i.e., to select for the recombinogenic subpopulation) and then screened for integration of the unselected product(s) via multiplex allele-specific colony PCR (MASC-PCR) exactly as previously described (Wang et al., 2009; Dalia et al., 2014b) . For MASC-PCR, PCR reactions are performed with a mixture of primers to detect multiple mutations in a single reaction.
The selected product used throughout this study replaced VC1807, a frame-shifted transposon, with either a kanamycin, spectinomycin, or trimethoprim resistance cassette. Diverse unselected products were used to generate all of the strains described throughout the study. The 13 EIIC-domain containing genes were targeted for inactivation by using unselected products that replace 501bp of the 5 0 end of each gene with a 23bp sequence that contains a stop codon in all three forward reading frames: 5 0 -ATGGCCGCTTAAACTGAATTAGC-3 0 . To generate the D13IIC strain, MuGENT was carried out in 5 cycles. At each cycle, 5 unselected products (targeting 5 distinct PTS transporters) were used along with a DVC1807::Ab R selected product. Following each cycle, 24-48 colonies were screened by MASC-PCR. The clone with the most unselected products integrated was then grown and used for subsequent cycles of MuGENT with 5 additional unselected genome edits. Cycles of MuGENT were carried out in this manner until all 13 PTS transporters were inactivated in a single background to yield the D13IIC strain. For a list of primers used to make and detect all mutant strains, see Supporting Information Table S3 . Transposon mutagenesis of V. cholerae was carried out exactly as previously described (Dalia et al., 2014a; McDonough et al., 2016) .
Whole genome sequencing
Sequencing libraries were generated exactly as previously described ) and analyzed as previously described (Seed et al., 2014; Dalia et al., 2015) using CLC Genomics WorkBench v6.8.
Growth curves and fluorescence measurements
For growth curves, bacteria were grown overnight in LB medium, and subsequently rinsed in M9 minimal medium. Then, $10 6 bacteria were transferred to 200 lL M9 medium with the indicated carbon source in a 96-well plate. Growth was kinetically monitored by measuring the optical density at 600 nm (OD 600 ) on a Biotek H1M plate reader with incubation at 378C and double orbital shaking between readings. For GFP fluorescence measurements, cells were grown to mid-log, rinsed, resuspended in instant ocean medium, and then transferred to a 96-well plate. Fluorescence was measured on a Biotek H1M plate reader at an excitation of 500 nm and emission of 540 nm.
Glucokinase activity assay
Assays were performed exactly as previously described (Skarlatos and Dahl, 1998) . Briefly, cells were grown in LB medium to mid-log and then $10 9 cells were lysed using a FastPrep instrument (MP Biomedical). Lysate was then added to a reaction containing 50 mM Tris-HCl pH 7.0, 25 mM MgCl 2 , 0.5 mM NADP, 1 mM ATP, 1 U of G6PDH (Sigma Aldrich), and 20mM glucose where indicated. The A 340 of each reaction was kinetically monitored on a Biotek H1M plate reader.
Measuring intracellular glucose
Cells were first grown in LB to mid-log Á 10 10 cells were then washed and resuspended in M9 1 Glucose medium and incubated at 308C for 15 min to allow for uptake of glucose. Cells were then chilled on ice, spun, and washed three times in ice-cold M9 medium lacking any carbon source. Cells were then lysed on a FastPrep instrument and glucose concentration in cell lysates was determined using a glucose oxidase-based kit according to manufacturers instructions (Sigma). Results are reported as the lg glucose per 10 8 CFUs.
Measuring intracellular glucose-6-phosphate
Cells were grown and lysates prepped as described above for measuring intracellular glucose. G6P was measured using a modified version of the glucokinase activity assay. Lysate was incubated in a reaction containing 50mM TrisHCl pH 7.0, 25 mM MgCl 2 , 0.5 mM NADP, and 1mM ATP. Two reactions were prepared for each sample -one where 1U G6PDH was added and one where no G6PDH was added. The difference in NADP reduction observed between these two samples was used to determine the G6P concentration in the cell lysates. G6P levels in lysates were determined against a standard curve and are reported as the lg of G6P per 10 8 CFUs.
qRT-PCR
Transcript abundance was measured by qRT-PCR exactly as previously described (Dalia et al., 2013; 2014a) . Data were first normalized to rpoB and then normalized to the control sample indicated in each experiment. A list of primers used in qRT-PCR experiments can be found in Supporting Information Table S3 .
Infection of infant mice
All animal experiments were performed in accordance with the rules and regulations of the department of Laboratory Animal Resources (LAR) and were approved by the Bloomington Institutional Animal Care and Use Committee (BIA-CUC) at Indiana University. The suckling infant mouse model of cholera was performed exactly as previously described (Seed et al., 2012) .
